260 / 464
260
POSTERS AND ELECTRONIC POSTERS
| Programme and Exhibition Guide
ELECTRONIC POSTERS
> SBRT benefit in oligometastatic prostate cancer patients detected by
[18F]fluoromethylcholine PET/CT
E. Bouman-Wammes (The Netherlands), J.M. Van Dodewaard- de Jong,
M. Dahele, M.C.F. Cysouw, O.S. Hoekstra, A.H.M. Piet,
A.J.M. Van den Eertwegh, H.M.W. Verheul, D.E. Oprea-Lager, V.M. H.
EP-1356
> Moderate hypofractionated-imrt of prostate bed after radical
prostatectom: acute toxicity
J. Valero Albarran (Spain), A. Ruiz Herrero, A. Montero, E. Sanchez,
E. Castro, D. Olmos, M. Hernandez, R. Ciervide, X. Chen, B. Alvarez,
M. Garcia Aranda, M. Lopez, M. Serrano, L. Osorio, M. Asenjo,
P. Fernandez Leton, A. Acosta, O. Hernando Requejo, C. Rubio
EP-1357
> Prostate postoperative hypofractionated radiotherapy: a single
institution experience with Tomo
S. Gomellini (Italy), B. Shima, R. Barbara, C. Caruso, A.D. Andrulli,
U. De Pula
EP-1358
> Pain response in a population-based study of Radium-223 for
metastatic prostate cancer
S. Tyldesley (Canada), S. Parimi, E. Tsang, F. Bachand, M. Aparicio,
G. Duncan, K. Sunderland, R. Olson, H. Pai, A. Alexander, V. Lapointe,
K. Chi
EP-1359
> Stereotactic body radiotherapy for oligometastatic prostate cancer
recurrence after local treatment.
P.A. Laurent (France), E. Martin, F. Cousin, M. Quivrin, F. Bidault,
F. Mazoyer, A. Bertaut, G. Crehange
EP-1360
> Prostate SBRT in 5 fractions, report of 185 patients and late toxicity
analysis.
P. Castro Peña (Argentina), O. Muriano, A. Henao, P. Murina,
C. Niño de Guzman, D. Venencia, S. Zunino
EP-1361
> Correlations between dose to small intestine and bladder volume in
patients receiving pelvic IMRT
M. Alfayez (UK), A. Sadozye
EP-1362
> Clinical efficacy of a dose escalated and hypofractionated pelvic IMRT
study in prostate cancer
A. Khan (UK), K. Thomas, L. Truelove, M. Ferreira, S. Gulliford,
H. McNair, C. Parker, R. Huddart, D. Dearnaley
EP-1363